EDIT:NASDAQ
Editas Medicine Inc
US$1,68
arrow_downward
-1,75%(-0,030) 1D
20 ພ.ຈ., 14 ໂມງ 11 ນາທີ 49 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$1,69
High
US$1,78
Low
US$1,66
Mkt. cap
259,29 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
1,20 ລ້ານ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
Open
US$1,69
High
US$1,78
Low
US$1,66
Mkt. cap
259,29 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
1,20 ລ້ານ
52-wk high
US$3,94
52-wk low
US$1,66
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
News stories
From web sources and news partners
Barron's
·
35 ນາທີກ່ອນ
S&P 500’s Tech Sector Crosses Bear Market Threshold
New York Post
·
23 ນາທີກ່ອນ
S&P 500 and Dow enter correction territory, Nasdaq loses 2026 gains as Anthropic dives
Investor's Business Daily
·
1 ຊົ່ວໂມງກ່ອນ
This VIX Signal Is Bullish For The S&P 500.
WSJ
·
8 ຊົ່ວໂມງກ່ອນ
S&P 500 Flirts With Correction
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedພ.ຈ. 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com